Business Context and Reporting Period
This Form 8-K was filed by Innventure, Inc. on December 13, 2024, reporting events occurring on December 9, 2024. The filing details the approval of equity compensation awards by the Compensation Committee of the Board of Directors under the Company's 2024 Equity and Incentive Compensation Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation arrangements.
Material Changes and Executive Compensation
On December 9, 2024, the Compensation Committee approved Restricted Stock Units (RSUs) and Stock Options for the Chief Financial Officer and two Named Executive Officers (NEOs). The Stock Options carry an exercise price of $12.20, reflecting the closing price of the Common Stock on the grant date.
- David Yablunosky (CFO): Granted 336,066 RSUs and 163,934 Stock Options.
- Michael Otworth (NEO): Granted 537,705 RSUs and 262,295 Stock Options.
- Dr. John Scott (NEO): Granted 336,066 RSUs and 163,934 Stock Options.
Outlook, Risks, and Vesting Terms
Vesting schedules vary by recipient and are contingent upon continuous service:
- Mr. Yablunosky: RSUs vest in three equal installments starting May 1, 2025. Stock Options vest 25% on May 1, 2025, with the remaining 75% vesting in eight equal quarterly installments thereafter.
- Mr. Otworth and Dr. Scott: RSUs and Stock Options vest 100% on October 2, 2025, or earlier if the contractual lock-up agreement entered into on October 24, 2023, terminates.
The filing references specific legal agreements (Exhibits 10.1 and 10.2) for complete terms and conditions.
Investor Verification Checklist
- Verify the total number of shares authorized under the 2024 Equity and Incentive Compensation Plan to assess remaining capacity for future grants.
- Review the specific vesting conditions and performance metrics (if any) detailed in Exhibits 10.1 and 10.2.
- Confirm the status and termination date of the "Contractual Lock-Up" agreement referenced for Mr. Otworth and Dr. Scott.
- Monitor the impact of these grants on potential dilution to existing shareholders.